ES2080922T3 - Derivados de la n-sulfonil-indolina, su preparacion, y las composiciones farmaceuticas que los contienen. - Google Patents
Derivados de la n-sulfonil-indolina, su preparacion, y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2080922T3 ES2080922T3 ES91402123T ES91402123T ES2080922T3 ES 2080922 T3 ES2080922 T3 ES 2080922T3 ES 91402123 T ES91402123 T ES 91402123T ES 91402123 T ES91402123 T ES 91402123T ES 2080922 T3 ES2080922 T3 ES 2080922T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- group
- rent
- noftil
- nitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- -1 AMINO Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 2
- 101150018198 COX1 gene Proteins 0.000 abstract 1
- 101150043980 COXI gene Proteins 0.000 abstract 1
- 102100030878 Cytochrome c oxidase subunit 1 Human genes 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 1
- 101150079116 MT-CO1 gene Proteins 0.000 abstract 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
- 102000002852 Vasopressins Human genes 0.000 abstract 1
- 108010004977 Vasopressins Proteins 0.000 abstract 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
- 150000003857 carboxamides Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960003726 vasopressin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA: EN LA QUE COXI EN C SUB 1-C SUB 4, UN HIDROXILO, UN GRUPO BENALOXI, CIANO, TRIFLUOROMETILO, NITRO O AMINO; UILO EN C SUB 1-C SUB 6, UN CICLOALQUILO EN C SUB 3-C SUB 7, UN CICLOALCENO EN C SUB 5-C SUB 7, UN FENILO NO SUSTITUIDO , MONO UB 4, UN HALOGENO, UN GRUPO TRIFLUOROMETILO, NITRO O AMINO; R SUB 3 REPRESENTA UN ATOMO DE HIDROGENO O UN ALQUILO EN C SUB 1-C SUB 4; LCOXICARBONILO EN C SUB 1-C SUB 6, UN GRUPO BENCILOXICARBONILO O UN GRUPO CARBOXAMIDA DE FORMULA CONR SUB 6 R SUB 7; 5 REPRESENTA UN ALQUILO EN C SUB 1-C SUB 4; UN NOFTIL-1; UN NOFTIL-2; UN DIMETILAMINO-5 NOFTIL-1; UN FENILO NO SUSTITUIDO O SUSTITUIDO POR UNO O VARIOS SUSTITUTOS ELEGIDOS ENTRE UN HALOGENO, UN ALQUILO EN C SUB 1-C SUB 4, UN GRUPO TRIFLUOROMETILO, NITRO, AMINO LIBRE O SUSTITUIDO POR UNO O 2 ALQUILOS EN C SUB 1-C SUB 4, UN HIDROXILO, UN ALCOXI EN C SUB 1-C SUB 4, UN ALCENOXI EN C SUB 1-C SUB 4, UN ALQUILTIO EN C SUB 1-C SUB 4, UN GRUPO TRIFLUOROMETOXI, BENCILOXI, CIANO, CARBOXI, ALCOXICARBONILO EN C SUB 1-C SUB 4, CARBAMOILO O ALQUILAMIDO EN C SUB 1-C SUB 4, O, CUANDO M = 0, R SUB 5 PUEDE REPRESENTAR UN GRUPO: SUB 6 Y R SUB 7 REPRESENTAN CADA UNO INDEPENDIENTEMENTE HIDROGENO; UN ALQUILO EN C SUB 1-C SUB 6, UN FENILALQUILO EN EL QUE EL ALQUILO ESTA EN C SUB 1-C SUB 4 O R SUB 6 Y R SUB 7, JUNTOS CONSTITUYEN UNA AGRUPACION -(CH SUB 2) SUB P-; 0,1 O 2 SUS SALES EVENTUALES. ESTOS COMPUESTOS TIENEN UNA AFINIDAD PARA LOS RECEPTORES DE LA VASOPRESINA Y DE LA OCITOCINA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9009778A FR2665441B1 (fr) | 1990-07-31 | 1990-07-31 | Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2080922T3 true ES2080922T3 (es) | 1996-02-16 |
Family
ID=9399281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91402123T Expired - Lifetime ES2080922T3 (es) | 1990-07-31 | 1991-07-30 | Derivados de la n-sulfonil-indolina, su preparacion, y las composiciones farmaceuticas que los contienen. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0469984B1 (es) |
| JP (1) | JP3195381B2 (es) |
| KR (1) | KR100211434B1 (es) |
| AT (1) | ATE129236T1 (es) |
| AU (2) | AU645585B2 (es) |
| CA (1) | CA2048139C (es) |
| DE (1) | DE69113911T2 (es) |
| ES (1) | ES2080922T3 (es) |
| FI (1) | FI97224C (es) |
| FR (1) | FR2665441B1 (es) |
| HU (1) | HU220765B1 (es) |
| IE (1) | IE73452B1 (es) |
| IL (2) | IL99012A (es) |
| NO (1) | NO175254C (es) |
| NZ (1) | NZ239182A (es) |
| PT (1) | PT98476B (es) |
| ZA (1) | ZA916031B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338755A (en) * | 1990-07-31 | 1994-08-16 | Elf Sanofi | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
| US5481005A (en) * | 1990-07-31 | 1996-01-02 | Sanofi | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| CA2166974A1 (en) * | 1993-07-16 | 1995-01-26 | Mark G. Bock | Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| ATE216580T1 (de) * | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
| FR2714378B1 (fr) * | 1993-12-24 | 1996-03-15 | Sanofi Sa | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. |
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| EP1335901B1 (en) | 2000-10-17 | 2010-04-14 | Merck Serono SA | Pharmaceutically active sulfanilide derivatives |
| GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
| GB0116594D0 (en) | 2001-07-06 | 2001-08-29 | Cancer Res Ventures Ltd | Therapeutic compounds |
| US7468385B2 (en) | 2001-12-20 | 2008-12-23 | Laboratoires Serono Sa | Triazoles as oxytocin antagonists |
| EP2399903A1 (en) * | 2002-05-24 | 2011-12-28 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| BR0215986A (pt) * | 2002-12-20 | 2005-11-01 | Cancer Rec Tech Ltd | Composto, composição, uso de composto, e, método para o tratamento de uma condição proliferativa, para o tratamento de câncer e de uma condição mediada pela tioredoxina/tioredoxina reductase, para inibir a tioredoxina/tioredoxina reductase em uma célula, in vitro ou in vivo e, para regular e inibir a proliferação celular |
| FR2853650B1 (fr) * | 2003-04-10 | 2006-07-07 | Merck Sante Sas | Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance |
| FR2880023B1 (fr) | 2004-12-23 | 2007-02-23 | Sanofi Aventis Sa | Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique |
| FR2927625B1 (fr) | 2008-02-19 | 2010-03-12 | Sanofi Aventis | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique |
| FR2930249B1 (fr) | 2008-04-21 | 2010-05-14 | Sanofi Aventis | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique. |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025224168A1 (en) | 2024-04-24 | 2025-10-30 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3838167A (en) * | 1972-08-01 | 1974-09-24 | Lilly Co Eli | Process for preparing indoles |
| US4479963A (en) * | 1981-02-17 | 1984-10-30 | Ciba-Geigy Corporation | 1-Carboxyalkanoylindoline-2-carboxylic acids |
| DE3705934A1 (de) * | 1987-02-25 | 1988-09-08 | Nattermann A & Cie | Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB8820129D0 (en) * | 1988-08-24 | 1988-09-28 | Schering Agrochemicals Ltd | Fungicides |
| FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
-
1990
- 1990-07-31 FR FR9009778A patent/FR2665441B1/fr not_active Expired - Fee Related
-
1991
- 1991-07-29 FI FI913614A patent/FI97224C/fi not_active IP Right Cessation
- 1991-07-29 PT PT98476A patent/PT98476B/pt not_active IP Right Cessation
- 1991-07-30 NZ NZ239182A patent/NZ239182A/en unknown
- 1991-07-30 CA CA002048139A patent/CA2048139C/en not_active Expired - Fee Related
- 1991-07-30 EP EP91402123A patent/EP0469984B1/fr not_active Expired - Lifetime
- 1991-07-30 DE DE69113911T patent/DE69113911T2/de not_active Expired - Fee Related
- 1991-07-30 ES ES91402123T patent/ES2080922T3/es not_active Expired - Lifetime
- 1991-07-30 IL IL9901291A patent/IL99012A/en not_active IP Right Cessation
- 1991-07-30 NO NO912970A patent/NO175254C/no not_active IP Right Cessation
- 1991-07-30 AT AT91402123T patent/ATE129236T1/de not_active IP Right Cessation
- 1991-07-31 AU AU81478/91A patent/AU645585B2/en not_active Ceased
- 1991-07-31 ZA ZA916031A patent/ZA916031B/xx unknown
- 1991-07-31 HU HU9102552A patent/HU220765B1/hu not_active IP Right Cessation
- 1991-07-31 JP JP19207891A patent/JP3195381B2/ja not_active Expired - Fee Related
- 1991-07-31 KR KR1019910013249A patent/KR100211434B1/ko not_active Expired - Fee Related
- 1991-07-31 IE IE269691A patent/IE73452B1/en not_active IP Right Cessation
-
1993
- 1993-11-05 AU AU50473/93A patent/AU664491B2/en not_active Ceased
-
1995
- 1995-08-15 IL IL11493495A patent/IL114934A0/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2080922T3 (es) | Derivados de la n-sulfonil-indolina, su preparacion, y las composiciones farmaceuticas que los contienen. | |
| AR034792A1 (es) | Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica | |
| FI961506A0 (fi) | Distamysiini A -analogit antituumorisina ja antiviraalisina aineina | |
| CR6805A (es) | Derivados novedosos de eter de propargil-fenil | |
| AR033594A1 (es) | Un compuesto derivado de 3-aroilindol, su utilizacion, procedimientos para prepararlo, una composicion farmaceutica que lo contiene, un medicamento constituido por dicho compuesto, y compuestos intermediarios | |
| ES2188957T3 (es) | N-(4-(heteroarilmetil)fenil)-heteroarilaminas. | |
| ES2040276T3 (es) | Derivados de la indolizina, procedimiento para su preparacion y composiciones que los contienen. | |
| CO4970702A1 (es) | Quinolonas antimicrobianas, sus composiciones y sus usos | |
| DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
| AR040407A1 (es) | Compuestos heterociclicos inhibidores de la funcion del canal de potasio | |
| ES2155995T3 (es) | Compuestos de 4-fenilpiperidina. | |
| AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
| PA8547901A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| CO4480737A1 (es) | Compuestos parasiticidas | |
| UY25804A1 (es) | Derivados de 4-aroilpiperidina que son antagonistas de los receptores ccr-3 | |
| CO5550439A2 (es) | Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen | |
| AR027539A1 (es) | Nuevos derivados de 1,3-dihidro-2h-indol-2-ona, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen | |
| ES2097142T3 (es) | Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis. | |
| MX9306227A (es) | Nuevos derivados de taxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| MX9300433A (es) | Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen. | |
| CO5590858A2 (es) | Composicion fungicida basada en un derivado de piridilmetilbenzamida e iprovalicarb | |
| ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
| CO5580721A2 (es) | Composicion fungicida basada en al menos un derivado de piridilmetilbenzamida y al menos un derivado de ditiocarbamato | |
| ES2171306T3 (es) | Compuesto bajo la forma de isomero geometrico puro o de una mezcla de estos isomeros. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 469984 Country of ref document: ES |